AM-Pharma Announces Publication of In Vivo Acute Kidney Injury Study Demonstrating Ilofotase Alfa’s Dual Protective Mechanism

Study shows ilofotase alfa protects against ischemia-reperfusion induced acute kidney injury in rodents through the activation of adenosine receptors and the metabolism of extracellular adenosine triphosphate (ATP), a pro-inflammatory molecule UTRECHT, Netherlands–(BUSINESS WIRE)–AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced new data indicating that ilofotase alfa protects against … [Read more…]

Live Cell Imaging Global Market Expected to Reach $3.73 Billion in 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Live Cell Imaging Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global live cell imaging market is expected to grow from $3.41 billion in 2021 to $3.73 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The market is expected to grow to $5.50 billion in … [Read more…]

Global AL Amyloidosis Market Report to 2032 – Insight, Epidemiology and Market Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “AL Amyloidosis – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report deliver an in-depth understanding of the AL Amyloidosis, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The … [Read more…]

Global Liquid Biopsy Market Report 2022: Rising Applications of Liquid Biopsy Expected to Boost Demand – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Liquid Biopsy Market, Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of … [Read more…]

Insights on the Glucose Biosensors Global Market Report to 2027 – Expanding Consumer Expenditures for Point of Care and Home Care Solutions Worldwide Present Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Glucose Biosensors Market Research Report by Type (Electrochemical Biosensor and Optical Biosensor), End Use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Glucose Biosensors Market size was estimated at USD 12.98 billion in … [Read more…]

Global Viral Vector Manufacturing Market Research Report to 2027 – Featuring Oxford BioMedica, Sanofi and Thermo Fisher Scientific Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Viral Vector Manufacturing Market Research Report by Type, Disease, Application, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Viral Vector Manufacturing Market size was estimated at USD 751.67 million in 2021 and expected to reach USD 890.28 million in 2022, and … [Read more…]

Human Gene Sequencing Market Report 2022: A Crowded Growing Global Market with Complicated Packaging and Pricing is Emerging with Unlimited Growth Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Human Gene Sequencing Markets, Strategies & Trends – Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides” report has been added to ResearchAndMarkets.com’s offering. The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent … [Read more…]

Innovaderm is Pleased to Announce the Acquisition of Excelsus Statistics

MONTREAL–(BUSINESS WIRE)–#DermatologyCRO–Innovaderm, a leading CRO in dermatology, has expanded its biometrics capacity following the acquisition of Excelsus Statistics, a Montreal-based company specialized in biostatistical and SAS programming services with a special expertise in adaptive trial design, as well as activities in many different therapeutic areas. “We are pleased to grow our Biometrics team with the … [Read more…]

Real Leaders® Selects Animated Insights™ as an Inaugural Eco Innovation Award Winner

Animated Insights™ is featured in the Q3 2022 issue of Real Leaders magazine NEW YORK–(BUSINESS WIRE)–#ai–This week, Real Leaders® selected Animated Insights™ Inc. as a winner at its inaugural Eco Innovation Awards launch to its global community of social impact executives. This distinction celebrates achievement in environmental impact. As a longtime advocate for businesses that … [Read more…]

Amylyx Pharmaceuticals Announces FDA Plan to Reconvene Advisory Committee to Review AMX0035 NDA for the Treatment of ALS on September 7, 2022

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA” or the “Agency”) has informed the Company that the Agency is planning to reconvene the Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) to discuss the New Drug Application (NDA) for AMX0035 (sodium … [Read more…]